FDA Inspection
Musculoskeletal Transplant Foundation - TSABMusculoskeletal Transplant Foundation - TSAB – FDA Inspection, Jan 14, 2009
Record Details
This FDA Inspection record concerns Musculoskeletal Transplant Foundation - TSAB, with an inspection on January 14, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 14, 2009
- Product Type
- Biologics
View Company Profile
ID · b2bb6300-f731-4047-87d9-62b6c8552609
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 557665
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.265(b)Shipment in quarantine of HCT/Ps
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Musculoskeletal Transplant Foundation - TSAB
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 9, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 7, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 26, 2010 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Musculoskeletal Transplant Foundation - TSAB
- FDA Inspection 1017172 - 2017-06-16
- FDA Inspection 921627 - 2015-04-09
- FDA Inspection 813104 - 2013-01-07
- FDA Inspection 695079 - 2010-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.